Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Moodys
Baxter
Dow
McKinsey

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INVANZ

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Invanz

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00379951 A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048) Completed Merck Sharp & Dohme Corp. Phase 3 2005-06-01 The purpose of this study is to evaluate the safety, tolerability and efficacy of ertapenem sodium as initial therapy for the treatment of complicated urinary tract infections, including pyelonephritis in indian adults.
NCT00397956 To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053) Completed Merck Sharp & Dohme Corp. Phase 3 2004-09-01 To collect clinical response data with the use of ertapenem in community acquired sepsis.
NCT00398099 To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052) Completed Merck Sharp & Dohme Corp. Phase 3 2005-07-01 To collect clinical response data with the use of ertapenem in approved indications.
NCT00877370 Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis Completed University of Michigan Phase 4 2009-02-01 Critically ill patients in the intensive care unit often receive continuous hemodialysis to treat their kidney failure. Ertapenem is an antibiotic often used in these patients. Continuous dialysis may remove ertapenem, putting patients at risk for inappropriate treatment of their infection. This study will determine how much ertapenem is removed by continuous hemodialysis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Invanz

Condition Name

Condition Name for Invanz
Intervention Trials
Urinary Tract Infection 3
Complicated Infection 2
End Stage Renal Disease 2
Antibiotic Resistant Infection 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Invanz
Intervention Trials
Infection 8
Communicable Diseases 8
Urinary Tract Infections 5
Intraabdominal Infections 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Invanz

Trials by Country

Trials by Country for Invanz
Location Trials
United States 26
India 5
Romania 4
Latvia 3
Bulgaria 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Invanz
Location Trials
California 3
Michigan 3
Texas 2
Nevada 2
Missouri 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Invanz

Clinical Trial Phase

Clinical Trial Phase for Invanz
Clinical Trial Phase Trials
Phase 4 4
Phase 3 9
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Invanz
Clinical Trial Phase Trials
Completed 10
Unknown status 3
Not yet recruiting 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Invanz

Sponsor Name

Sponsor Name for Invanz
Sponsor Trials
Merck Sharp & Dohme Corp. 7
Tetraphase Pharmaceuticals, Inc. 3
Iterum Therapeutics, US Limited 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Invanz
Sponsor Trials
Other 17
Industry 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Medtronic
Moodys
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.